Back

Identification and characterization of small-molecule ERBB4 agonists as a treatment for heart failure

22 May 2022 (17:40 - 17:50)
Organised by:
Congress Presentation Part of: New therapeutic approaches for heart failure Heart Failure HFA Premium Access Heart Failure 2022

About the speaker

Photo
Miss Eline Feyen

University of Antwerp, Antwerp (Belgium)

4 More presentations in this session

Presentation thumbnail
Repurposing of glatiramer acetate to treat cardiac ischemia
Doctor G. Aviel (Rehovot, IL)
Abstract Slides Video
Presentation thumbnail
FXa promotes endothelial dysfunction and pro-remodeling responses in atrial endothelial cells involving PAR1 and 2 and AT1R/NADPH oxidase/SGLT1/2 pro-oxidant pathways
Ms W. Fakih (Strasbourg, FR)
Abstract Slides Video
Presentation thumbnail
Repeated low doses of doxorubicin induce senescence and functional decline in dyn-EHTs which can be rescued using senomorphics.
Ms A. Linders (Groningen, NL)
Abstract Slides Video
Presentation thumbnail
Living myocardial slices for the study of nucleic acid-based therapies
Doctor R. Nunez-Toldra (London, GB)
Abstract Slides Video

Access the full session

Session thumbnail
New therapeutic approaches for heart failure
Video

The Event

Event poster

Heart Failure 2022

22 May 2022 17:40 CET
You may be interested in
thumbnail
Congress Presentation
Fetal recapitulation and cellular stress in the evolution and progression of heart failure
thumbnail
Congress Session
Heart Failure 2025 highlights
thumbnail
Congress Session
Unspoken aetiologies of heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources